perflutren has been researched along with Age-Related Macular Degeneration in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (26.67) | 18.2507 |
2000's | 7 (46.67) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Han, YS; Lee, SJ; Lim, JH; Nam, KY | 1 |
Byeon, SH; Choi, HJ; Choi, M; Chung, B; Lee, J; Shin, JY | 1 |
Hong, MC; Kung, YH; Sheu, SJ; Wu, TT | 1 |
Hesgaard, HB; la Cour, M; Torkashvand, M | 1 |
Hesse, L; Schulze, SD | 1 |
Cheng, L; Freeman, W; Monshizadeh, R; Rafiei, N; Smiddy, WE; Sullivan, PM; Tabandeh, H | 1 |
Kittantong, A; Ratanasukon, M | 1 |
Axer-Siegel, R; Ehrlich, R; Ron, Y; Rosenblatt, I; Weinberger, D | 1 |
Chen, MS; Fang, IM; Lin, YC; Yang, CH; Yang, CM | 1 |
Hayashi, A; Lewis, JM; Ohji, M; Saito, Y; Tano, Y | 1 |
Bird, AC; Fitzke, FW; Flaxel, CJ; Gabel, VP; Gross-Jendroska, M; Holz, FG; Schwartz, SD | 1 |
Hesse, L; Kroll, P; Schmidt, J | 1 |
Blodi, BA; Elner, SG; Hassan, AS; Johnson, MW; Poliner, LS; Regillo, CD; Schneiderman, TE; Tornambe, PE | 1 |
Heller, G; Hesse, L; Kroll, P; Schroeder, B | 1 |
Blodi, BA; Chandra, SR; Handwerger, BA; Olsen, TW; Stevens, TS | 1 |
1 trial(s) available for perflutren and Age-Related Macular Degeneration
Article | Year |
---|---|
Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm; Eye Injuries; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Postoperative Complications; Prone Position; Retinal Hemorrhage; Retinal Vessels; Retrospective Studies; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 1999 |
14 other study(ies) available for perflutren and Age-Related Macular Degeneration
Article | Year |
---|---|
Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration.
Topics: Aged; Female; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Risk Factors; Smoking; Tissue Plasminogen Activator; Vitreous Hemorrhage | 2020 |
Anti-Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body; Young Adult | 2010 |
Failure to detect an effect of pneumatic displacement in the management of submacular haemorrhage secondary to age-related macular degeneration: a retrospective case series.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Prone Position; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2012 |
Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Body | 2002 |
Characteristics and outcomes of choroidal neovascularization occurring after macular hole surgery.
Topics: Aged; Choroidal Neovascularization; Epiretinal Membrane; Female; Fluorescein Angiography; Fluorocarbons; Humans; Macular Degeneration; Male; Middle Aged; Postoperative Complications; Prone Position; Retinal Perforations; Retrospective Studies; Treatment Outcome; Visual Acuity; Vitrectomy | 2004 |
Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Fluorocarbons; Follow-Up Studies; Gases; Humans; Macular Degeneration; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Thailand; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2005 |
Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Pressure; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Visual Acuity | 2007 |
Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Gases; Humans; Macular Degeneration; Male; Middle Aged; Prognosis; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2009 |
Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator.
Topics: Aged; Aneurysm, Ruptured; Female; Fluorocarbons; Fundus Oculi; Humans; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Artery; Retinal Detachment; Retinal Hemorrhage; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Body; Vitreous Hemorrhage | 1998 |
Treatment of pigment epithelial detachments due to age-related macular degeneration with intra-ocular C3F8 injection.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Dark Adaptation; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Fundus Oculi; Humans; Injections; Laser Coagulation; Macular Degeneration; Middle Aged; Pilot Projects; Posture; Retinal Detachment; Visual Acuity; Vitreous Body | 1998 |
Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
Topics: Acute Disease; Aged; Aged, 80 and over; Electroretinography; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Fundus Oculi; Humans; Injections; Macular Degeneration; Male; Middle Aged; Recombinant Proteins; Retinal Hemorrhage; Tissue Plasminogen Activator; Treatment Outcome; Vitreous Body | 1999 |
Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2000 |
Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Male; Prone Position; Retinal Hemorrhage; Retrospective Studies; Safety; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2001 |